Former special adviser to PM launches firm to speed up clinical research
The founders say Lindus Health can offer clinical trials that lead to better health outcomes for the public.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A former special adviser to the Prime Minister has publicly launched a firm to speed up clinical research into new health treatments.
Michael Young, together with Meri Beckwith, launched Lindus Health with around £3.7 million in seed funding from technology and healthcare investors such as Firstminute Capital, Presight Capital, Seedcamp and Hambro Perks.
The pair aim to cut the costs of bringing new drugs to market through less expensive clinical trials and better technology, and have created a new clinical trial platform.
They say this will result in faster, safer clinical trials that lead to better health outcomes for the public.
Traditional clinical research companies are dinosaurs
Current trials run by Lindus include several from the universities of Oxford Leeds Brunel and Nottingham.
Mr Young said: “During my time in government, I heard time and time again that the way clinical trials are conducted is broken.
“This means that patients are missing out on lifesaving treatments.
“To fix this requires a totally new business model for clinical trials. So we founded Lindus Health to do just that and to enable the next generation of healthcare companies.”
Mr Beckwith said: “Traditional clinical research companies are dinosaurs.
“Taking part in a Covid vaccine trial was like stepping into a time machine.
“This was one of the best-funded trials in history but research was done on pen and paper and participants had to go into hospital at the height of the pandemic to fill out forms.
“We founded Lindus Health to make it easier for patients to participate in research, and accelerate the development of new treatments.”